{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:16:24Z","timestamp":1782951384788,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-033052"],"award-info":[{"award-number":["INV-033052"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R34 MH120106"],"award-info":[{"award-number":["R34 MH120106"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Private pharmacies are a primary access point for health services in many African countries. Leveraging private-sector pharmacies to deliver HIV prevention services, including pre- and post-exposure prophylaxis (PrEP\/PEP), may expand the reach of these services. Understanding delivery costs is necessary to inform scale-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used data from two pilot studies conducted in Kisumu County, Kenya. In the first pilot, pharmacy providers at 12 pharmacies delivered free PrEP\/PEP to eligible clients (\u2265\u200918 years) using a prescribing checklist with remote clinician oversight; PrEP\/PEP drugs were donated from government stock. Using microcosting, we estimated the economic and financial costs from the provider\u2019s perspective for: (1) subsidized delivery (donated commodities excluded), and (2) non-subsidized delivery (donated commodities included). We also assessed client willingness to pay for PrEP services at pharmacies using PrEP client survey data. In the second pilot, pharmacy providers at 20 pharmacies delivered HIV testing services. We assessed providers\u2019 anticipated willingness to deliver PrEP services using provider survey data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>From February to July 2022, pharmacies in the first pilot recorded 1,564 PrEP\/PEP visits, and initiated 691 clients on PrEP. Among clients eligible to continue PrEP at the pharmacy, 69% (479\/691) refilled at least once. We collected 694 surveys from PrEP clients. From March to June 2022, 40 providers in the second pilot completed surveys. The estimated economic (financial) costs per client-month on PrEP were $3.66 ($2.17) USD for subsidized and $13.23 ($11.74) USD for non-subsidized delivery, and for PEP were $3.66 ($2.15) USD for subsidized and $10.75 ($9.24) USD for non-subsidized delivery. Most PrEP clients (83%, 575\/691) expressed willingness to pay for pharmacy-delivered PrEP services; the median amount they were willing to pay per visit was $3.30 USD (IQR $1.60-$4.10 USD), which exceeded the median maximum amount providers said they would charge per visit ($2.40 USD, IQR $1.60-$4.10 USD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>When subsidized with drugs from government stock, pharmacies are a low-cost platform for delivering PrEP and PEP services in Kenya. Client out-of-pocket payments could help sustain pharmacy PrEP\/PEP delivery at scale, enabling broader coverage of HIV prevention services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-025-13681-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:36:47Z","timestamp":1764171407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Understanding the cost of pharmacy-delivered HIV pre- and post-exposure prophylaxis service delivery in Kenya: findings from pilot studies"],"prefix":"10.1186","volume":"25","author":[{"given":"Obinna I.","family":"Ekwunife","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra P.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetika","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengruo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Kiptinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Omollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Odoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bukusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ngure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monisha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina F.","family":"Ortblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"13681_CR1","unstructured":"UNAIDS, Country Factsheets. Kenya 2023 [Internet]. Geneva, Switzerland: Joint United Nations Programme on HIV\/AIDS and STRIVE; 2024 [cited 2023 Sep 5]. Available from: https:\/\/www.unaids.org\/en\/regionscountries\/countries\/kenya."},{"key":"13681_CR2","unstructured":"GPC. 2023 Global HIV Prevention Scorecard: Kenya [Internet]. [cited 2024 Sep 5]. Available from: https:\/\/hivpreventioncoalition.unaids.org\/en\/countries\/kenya"},{"issue":"1","key":"13681_CR3","doi-asserted-by":"publisher","first-page":"21484","DOI":"10.7448\/IAS.19.1.21484","volume":"19","author":"A Grimsrud","year":"2016","unstructured":"Grimsrud A, Bygrave H, Doherty M, Ehrenkranz P, Ellman T, Ferris R, et al. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression. J Int AIDS Soc. 2016;19(1):21484.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"13681_CR4","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1007\/s10461-021-03229-5","volume":"25","author":"SD Roche","year":"2021","unstructured":"Roche SD, Wairimu N, Mogere P, Kamolloh K, Odoyo J, Kwena ZA, et al. Acceptability and feasibility of pharmacy-based delivery of pre-exposure prophylaxis in Kenya: a qualitative study of client and provider perspectives. AIDS Behav. 2021;25(12):3871\u201382.","journal-title":"AIDS Behav"},{"key":"13681_CR5","doi-asserted-by":"crossref","unstructured":"Harrington EK, Casmir E, Kithao P, Kinuthia J, John-Stewart G, Drake AL et al. Spoiled girls: understanding social influences on adolescent contraceptive decision-making in Kenya. Ortega JA, editor. PLoS ONE. 2021;16(8):e0255954.","DOI":"10.1371\/journal.pone.0255954"},{"key":"13681_CR6","unstructured":"UNAIDS. In Danger: UNAIDS Global AIDS Update 2022 [Internet], Geneva S. 2022 [cited 2023 Feb 23]. Report No.: Licence: CC BY-NC-SA 3.0 IGO. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2022\/in-danger-global-aids-update"},{"issue":"4","key":"13681_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00038-020-01348-9","volume":"65","author":"L Gonsalves","year":"2020","unstructured":"Gonsalves L, Wyss K, Gichangi P, Hilber AM. Pharmacists as youth-friendly service providers: documenting condom and emergency contraception dispensing in Kenya. Int J Public Health. 2020;65(4):487\u201396.","journal-title":"Int J Public Health"},{"issue":"1","key":"13681_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1728-4465.2014.00376.x","volume":"45","author":"G Morgan","year":"2014","unstructured":"Morgan G, Keesbury J, Speizer I. Emergency contraceptive knowledge and use among urban women in Nigeria and Kenya. Stud Fam Plann. 2014;45(1):59\u201372.","journal-title":"Stud Fam Plann"},{"key":"13681_CR9","doi-asserted-by":"publisher","first-page":"1023568","DOI":"10.3389\/frph.2023.1023568","volume":"5","author":"HN Nakambale","year":"2023","unstructured":"Nakambale HN, Roche SD, Mogere P, Omollo V, Kuo AP, Stergachis A, et al. Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in kenya: an analysis of routine data. Front Reprod Health. 2023;5:1023568.","journal-title":"Front Reprod Health"},{"issue":"4","key":"13681_CR10","doi-asserted-by":"publisher","first-page":"594","DOI":"10.9745\/GHSP-D-16-00197","volume":"4","author":"M Corroon","year":"2016","unstructured":"Corroon M, Kebede E, Spektor G, Speizer I. Key role of drug shops and pharmacies for family planning in urban Nigeria and Kenya. Glob Health Sci Pract. 2016;4(4):594\u2013609.","journal-title":"Glob Health Sci Pract"},{"issue":"1","key":"13681_CR11","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1186\/s12913-020-05898-9","volume":"20","author":"KF Ortblad","year":"2020","unstructured":"Ortblad KF, Mogere P, Roche S, Kamolloh K, Odoyo J, Irungu E, et al. Design of a care pathway for pharmacy-based PrEP delivery in kenya: results from a collaborative stakeholder consultation. BMC Health Serv Res. 2020;20(1):1034.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"13681_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/QAD.0000000000003447","volume":"37","author":"J Pintye","year":"2022","unstructured":"Pintye J, Odoyo J, Nyerere B, Achieng P, Araka E, Omondi C, et al. Nurse-facilitated PrEP delivery for adolescent girls and young women seeking contraception at retail pharmacies in Kisumu, Kenya. AIDS. 2022;37(4):617\u201323.","journal-title":"AIDS"},{"issue":"6","key":"13681_CR13","doi-asserted-by":"publisher","first-page":"e26131","DOI":"10.1002\/jia2.26131","volume":"26","author":"KF Ortblad","year":"2023","unstructured":"Ortblad KF, Mogere P, Omollo V, Kuo AP, Asewe M, Gakuo S, et al. Stand-alone model for delivery of oral HIV pre\u2010exposure prophylaxis in kenya: a single\u2010arm, prospective pilot evaluation. J Int AIDS Soc. 2023;26(6):e26131.","journal-title":"J Int AIDS Soc"},{"key":"13681_CR14","unstructured":"Roche SD, Omollo V, Mogere P, Asewe M, Gakuo S, Banerjee P et al. Pharmacy-based PrEp delivery in Kenya: findings from a pilot study extension. In Seattle, Washington; 2023. Available from: https:\/\/www.croiconference.org\/abstract\/pharmacy-based-prep-delivery-in-kenya-findings-from-a-pilot-study-extension\/"},{"key":"13681_CR15","doi-asserted-by":"publisher","first-page":"232595822312158","DOI":"10.1177\/23259582231215882","volume":"22","author":"M Vera","year":"2023","unstructured":"Vera M, Bukusi E, Achieng P, Aketch H, Araka E, Baeten JM, et al. Pharmacies are Everywhere, and you can get it at any Time: experiences with Pharmacy-Based PrEP delivery among adolescent girls and young women in Kisumu, Kenya. J Int Assoc Provid AIDS Care. 2023;22:23259582231215882.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"10","key":"13681_CR16","doi-asserted-by":"publisher","first-page":"e26177","DOI":"10.1002\/jia2.26177","volume":"26","author":"KF Ortblad","year":"2023","unstructured":"Ortblad KF, Kwach B, Zhang S, Asewe M, Ongwen PA, Malen RC, et al. Measuring the performance of HIV self-testing at private pharmacies in kenya: a cross\u2010sectional study. J Int AIDS Soc. 2023;26(10):e26177.","journal-title":"J Int AIDS Soc"},{"key":"13681_CR17","unstructured":"National Syndemic Diseases Control Council. HIV estimates visualization at subcounty level [Internet]. 2024 [cited 2024 Nov 8]. Available from: https:\/\/analytics.nsdcc.go.ke\/estimates\/#!\/"},{"key":"13681_CR18","unstructured":"Medpages statistics \u2013 Pharmaceutical (Pharmacies, Distributors, etc.) in Kenya [Internet]. [cited 2024 May 14]. Available from: https:\/\/www.medpages.info\/sf\/index.php?page=categorystats%26countryid=23%26categoryid=9"},{"key":"13681_CR19","doi-asserted-by":"crossref","unstructured":"Haacker M, Hallett TB, Atun R. On discount rates for economic evaluations in global health. Health Policy Plann. 2019;czz127.","DOI":"10.1093\/heapol\/czz127"},{"key":"13681_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2018.01.111","volume":"93","author":"N Booth","year":"2018","unstructured":"Booth N, Rissanen P, Tammela TLJ, Taari K, Talala K, Auvinen A. Costs of screening for prostate cancer: evidence from the Finnish randomised study of screening for prostate cancer after 20-year follow-up using register data. Eur J Cancer. 2018;93:108\u201318.","journal-title":"Eur J Cancer"},{"issue":"9","key":"13681_CR21","first-page":"822","volume":"60","author":"G Adamiak","year":"2006","unstructured":"Adamiak G. Methods for the economic evaluation of health care programmes. J Epidemiol Community Health. 2006;60(9):822\u20133. 3rd ed.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"13681_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12962-023-00436-w","volume":"21","author":"HC Turner","year":"2023","unstructured":"Turner HC, Sandmann FG, Downey LE, Orangi S, Teerawattananon Y, Vassall A, et al. What are economic costs and when should they be used in health economic studies? Cost Eff Resour Alloc. 2023;21(1):31.","journal-title":"Cost Eff Resour Alloc"},{"issue":"1","key":"13681_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1186\/s12913-021-06832-3","volume":"21","author":"K Peebles","year":"2021","unstructured":"Peebles K, Mugwanya KK, Irungu E, Odoyo J, Wamoni E, Morton JF, et al. Low costs and opportunities for efficiency: a cost analysis of the first year of programmatic PrEP delivery in kenya\u2019s public sector. BMC Health Serv Res. 2021;21(1):823.","journal-title":"BMC Health Serv Res"},{"key":"13681_CR24","doi-asserted-by":"publisher","unstructured":"Roberts DA, Barnabas RV, Abuna F, Lagat H, Kinuthia J, Pintye J et al. The role of costing in the introduction and scale-up of HIV pre\u2010exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya. J Intern AIDS Soc [Internet]. 2019 Jul [cited 2023 Jan 15];22(S4). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/jia2.25296.","DOI":"10.1002\/jia2.25296"},{"key":"13681_CR25","doi-asserted-by":"crossref","unstructured":"Wanga V, Peebles K, Obiero A, Mogaka F, Omollo V, Odoyo JB et al. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya. Larson BA, editor. PLoS ONE. 2021;16(4):e0249625.","DOI":"10.1371\/journal.pone.0249625"},{"key":"13681_CR26","unstructured":"Ayub S, Wanjala L. Average salary in Kenya monthly and annually per person in 2024 - Tuko.co.ke [Internet]. 2023 [cited 2024 Nov 13]. Available from: https:\/\/www.tuko.co.ke\/343265-average-salary-kenya.html."},{"issue":"1","key":"13681_CR27","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/s12913-018-3490-2","volume":"18","author":"T Wellay","year":"2018","unstructured":"Wellay T, Gebreslassie M, Mesele M, Gebretinsae H, Ayele B, Tewelde A, et al. Demand for health care service and associated factors among patients in the community of Tsegedie District, Northern Ethiopia. BMC Health Serv Res. 2018;18(1):697.","journal-title":"BMC Health Serv Res"},{"key":"13681_CR28","unstructured":"Schreiber M. What\u2019s happening with the anti-HIV program PEPFAR? It depends whom you ask. NPR [Internet]. 2025 Feb 13 [cited 2025 Jul 29]; Available from: https:\/\/www.npr.org\/sections\/goats-and-soda\/2025\/02\/13\/nx-s1-5295011\/what-is-happening-with-pepfar-it-depends-whom-you-ask"},{"key":"13681_CR29","unstructured":"WHO. WHO statement on potential global threat. to people living with HIV [Internet]. [cited 2025 Feb 7]. Available from: https:\/\/www.who.int\/news\/item\/28-01-2025-who-statement-on-potential-global-threat-to-people-living-with-hiv"},{"issue":"6","key":"13681_CR30","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1177\/1078155219893742","volume":"26","author":"KB Mensah","year":"2020","unstructured":"Mensah KB, Oosthuizen F, Bangalee V. Cancer health promotion in ghana: A survey of community pharmacists\u2019 perception and barriers. J Oncol Pharm Pract. 2020;26(6):1361\u20138.","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"13681_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13690-022-00912-4","volume":"80","author":"A Nsengimana","year":"2022","unstructured":"Nsengimana A, Biracyaza E, Hategekimana JC, Tuyishimire J, Nyiligira J, Rutembesa E. Attitudes, perceptions, and barriers of community pharmacists in Rwanda towards health promotion: a cross sectional study. Arch Public Health. 2022;80(1):157.","journal-title":"Arch Public Health"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13681-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13681-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13681-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:36:50Z","timestamp":1764171410000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13681-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13681"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13681-x","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Scientific Ethics Review Unit at the Kenya Medical Research Institute (Nairobi, Kenya), the Human Subjects Division at the University of Washington (Seattle, USA), and Fred Hutch Cancer Center (Seattle, USA) all reviewed and approved the study protocols for both pilots. All human subjects gave written informed consent and received 500 KSH (~$5 USD) for completing research-related activities (e.g., surveys). Information given to study participants on confidentiality, options for withdrawal, and data management practices were in accordance with the Helsinki Declaration of Ethical Principles and the General Data Protection Regulation in Kenya.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1536"}}